Clinical Analysis: 75-Year-Old Man with Hypochromic/Normochromic Normocytic Anemia, Low-Normal EPO, Creatinine 1.75 mg/dL

Interpreting the Garbled Query

• Hypochromic normocytic anemia (pale red cells with normal MCV)
• Serum erythropoietin (EPO) slightly below normal (relative EPO deficiency)
• Serum creatinine 1.75 mg/dL - this corresponds to mild-to-moderate CKD (estimated GFR likely 30-45 mL/min in a 75-year-old male - Stage 3 CKD)

Most Likely Diagnosis: Anemia of Chronic Kidney Disease (CKD)

• The kidneys are the primary site of EPO production. As renal function declines, EPO output falls.
• A creatinine of 1.75 in a 75-year-old man (low muscle mass) likely corresponds to an eGFR of ~35-42 mL/min/1.73 m² - right at the threshold where anemia begins.
• Goldman-Cecil Medicine states: "Anemia is almost invariable in significant renal insufficiency, beginning when the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73 m²" - this patient likely sits just at or below this threshold.
• The major pathogenetic factor is EPO deficiency - the kidneys simply cannot produce enough EPO to stimulate the bone marrow adequately.

• Goldman-Cecil notes: "Erythropoietin concentrations are generally not helpful in making a diagnosis because the usual feedback relationship between hemoglobin concentration/hematocrit and erythropoietin secretion is lost."
• In normal physiology, anemia should cause a large compensatory rise in EPO. In CKD, the EPO response is inappropriately blunted - so the EPO level may appear near-normal or only slightly low, but it is far lower than what the degree of anemia demands. This is called relative EPO deficiency.

• Classically normocytic and normochromic (or mildly hypochromic if iron stores are also depleted)
• Echinocytes ("burr cells") may be seen
• Reticulocyte count is low relative to the degree of anemia (hypoproliferative pattern)

Diagnostic Flowchart

Differential Diagnoses to Consider

Workup Recommended

1. CBC with reticulocyte count - expect low reticulocyte index
2. Iron studies (serum iron, TIBC, ferritin, transferrin saturation) - rule out concurrent iron deficiency
3. eGFR calculation (CKD-EPI using creatinine + age + sex)
4. Peripheral blood smear - look for echinocytes, dysplastic cells
5. TSH - rule out hypothyroidism
6. B12/folate - rule out concurrent deficiency
7. Serum EPO level - may be "inappropriately normal" for degree of anemia
8. Urinalysis + urine protein/creatinine ratio - characterize CKD further

Management of CKD Anemia

• Erythropoiesis-stimulating agents (ESAs): recombinant EPO (epoetin alfa) or darbepoetin alfa. Target Hb of 9-11 g/dL - NOT full correction to normal (Hb > 13 g/dL is associated with increased risk of stroke, MI, and thrombosis).
• Treatment threshold: Start ESA when Hb < 9 g/dL; suspend when Hb reaches 9-11 g/dL.
• Iron supplementation: Essential - check if transferrin saturation < 30% or ferritin < 500 ng/mL. IV iron is preferred over oral because hepcidin (elevated in CKD) impairs oral iron absorption.
• Daprodustat: Oral HIF prolyl hydroxylase inhibitor, FDA-approved for dialysis patients - stimulates endogenous EPO production and regulates iron metabolism.
• Resistance to ESA most often indicates iron deficiency or concurrent inflammation.

Key Teaching Points

1. In CKD, EPO levels are "inappropriately normal" - not dramatically low - because the normal EPO-to-anemia feedback is broken. A slightly low or even normal EPO in the context of significant anemia IS the pathology.
2. Creatinine 1.75 in a 75-year-old man underestimates the degree of renal impairment because muscle mass (the source of creatinine) declines with age. The true eGFR is likely lower than you'd calculate in a younger person with the same creatinine.
3. Anemia of CKD is normocytic and normochromic classically - but hypochromia can appear if iron deficiency coexists (very common, especially in elderly patients with poor nutrition or chronic blood loss).